A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC)

被引：0
作者：
Carducci, M. [1 ]
Armstrong, A. [2 ,3 ]
Pili, R. [4 ]
Ng, S. [5 ]
Huddart, R. [6 ]
Agarwal, N. [7 ]
Khvorostenko, D. [8 ]
Lyulko, O. [9 ]
Brize, A. [10 ]
Vogelzang, N. J. [11 ]
Delva, R. [12 ]
Harza, M. [13 ]
Thanos, A. [14 ]
James, N. [15 ]
Werbrouck, P. [16 ]
Boegemann, M. [17 ]
Hutson, T. [18 ]
Milecki, P. [19 ]
Nederman, T. [20 ]
Sternberg, C. [21 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Duke Canc Inst, Div Med Oncol, Durham, NC USA
[3] Duke Canc Inst, Div Urol, Durham, NC USA
[4] Indiana Univ Sch Med, Div Hematol Oncol, Dept Med, Indianapolis, IN 46202 USA
[5] St John God Hosp, Ivy Suite Canc Ctr, Subiaco, WA, Australia
[6] Royal Marsden Hosp, Clin Oncol, Sutton, Surrey, England
[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[8] Leningrad Reg Oncol Dispensary, St Petersburg, Russia
[9] Municipal Inst Zaporizhzhia Reg Clin Hosp, Dept Urol, Zaporizhzhya, Ukraine
[10] Riga Eastern Clin Univ Hosp, Latvian Oncol Ctr, Riga, Latvia
[11] US Oncol & Comprehens Canc Ctr Nevada, Med Oncol, Las Vegas, NV USA
[12] Ctr Reg Lutte Canc Paul Papin, Serv Oncol Med, Angers, France
[13] Fundeni Clin Inst, Dept Urol, Bucharest, Romania
[14] Hosp Athens, Urol Clin, Agios Savas Anticanc Oncol, Athens, Greece
[15] Univ Warwick, Canc Res Unit, Warwick, England
[16] AZ Groeninge, Dept Urol, Kortrijk, Belgium
[17] Univ Klinikum Munster, Klin & Polikklin Urol, Munster, Germany
[18] Texas Oncol PA, Collins Bldg, Dallas, TX USA
[19] Wielkopolskie Ctr Onkol, Dept Radiotherapy, Poznan, Poland
[20] Act Biotech AB, Clin Dev, Lund, Sweden
[21] San Camillo & Forlanini Hosp, Dept Med Oncol, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31934-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4BA
引用
收藏
页码：S713 / S714
页数：2
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
    Robert Dreicer
    Jorge Garcia
    Brian Rini
    Nicholas Vogelzang
    Sandy Srinivas
    Bradley Somer
    Peipei Shi
    Marek Kania
    Derek Raghavan
    Investigational New Drugs, 2013, 31 : 1044 - 1050
  • [32] REGENERATE: A Global Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of OCA for NASH
    Ratziu, Vlad
    Sanyal, Arun J.
    MacConell, Leigh
    Herrmann, Sibylle
    Shringarpure, Reshma
    Marmon, Tonya
    Shapiro, David
    Younossi, Zobair M.
    SWISS MEDICAL WEEKLY, 2016, 146 : 17S - 17S
  • [33] A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
    Dreicer, Robert
    Garcia, Jorge
    Rini, Brian
    Vogelzang, Nicholas
    Srinivas, Sandy
    Somer, Bradley
    Shi, Peipei
    Kania, Marek
    Raghavan, Derek
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 1044 - 1050
  • [34] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Hu, Bo
    Li, Gang
    Li, Xiaohong
    Wu, Shan
    Yu, Tingmin
    Li, Xiang
    Zhao, Hongru
    Jia, Zhihua
    Zhuang, Junpeng
    Yu, Shengyuan
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01)
  • [35] Zonisamide improves DLB parkinsonism: A randomized double-blind placebo-controlled phase 3 study
    Murata, M.
    Odawara, T.
    Hasegawa, K.
    Kajiwara, R.
    Takeuchi, H.
    Tagawa, M.
    Kosaka, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 185 - 186
  • [36] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [37] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06) : 439 - 448
  • [38] Dietary intervention in prostate cancer patients:: PSA response in a randomized double-blind placebo-controlled study
    Kranse, R
    Dagnelie, PC
    van Kemenade, MC
    de Jong, FH
    Blom, JHM
    Tijburg, LBM
    Weststrate, JA
    Schröder, FH
    INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (05) : 835 - 840
  • [39] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
    Bo Hu
    Gang Li
    Xiaohong Li
    Shan Wu
    Tingmin Yu
    Xiang Li
    Hongru Zhao
    Zhihua Jia
    Junpeng Zhuang
    Shengyuan Yu
    The Journal of Headache and Pain, 2022, 23
  • [40] ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Tarantino, M.
    Bussel, J.
    Blanchette, V.
    Despotovic, J.
    Bennett, C.
    Raj, A.
    Williams, B.
    Beam, D.
    Morales, J.
    Rose, M.
    Carpenter, N.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 137 - 137
12345